First Female Professional CEO in Samsung Group’s history

Samsung Bioepis Appoints Kim Kyung-ah as New CEO After 13 Years

Presented at the Asia-Pacific Digestive Disease Week

Daewoong "Ursa Shows Liver Function Improvement in Phase 4 Trial"

Celltrion Secures First Approval for Prolia Biosimilar in Korea

Signs 930.4 Billion KRW Contract with European Pharmaceutical Company

Samsung Biologics Breaks 5 Trillion KRW in Annual Orders for the First Time

Accelerated Global Expansion Expected

FDA Approved VUNO’s AI Chest X-ray Diagnostic Device

First Major Pharma Collaboration... Expansion Beyond Lung Cancer Expected

Lunit Partners with AstraZeneca to Develop ‘AI Pathology Solution’

"Switching to Direct Sales Model"

Celltrion Acquires Swiss Pharmaceutical Distributor, iQone Healthcare Switzerland

Park Soon-Jae, CEO of Alteogen: “Creating a ‘Golden Egg’ Platform”

Global Pharma Companies Lining Up at Alteogen's Door – Why?

The event comprised lecture and live demonstration for facial filler injection

Hugel Successfully Concludes HA Filler workshop for French medical experts

echnology to Develop Subcutaneous Injection for ADC Cancer Drug 'Enhertu'

Alteogen Signs USD 280 Million Licensing Agreement with Daiichi Sankyo